{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:55:53Z","timestamp":1769302553706,"version":"3.49.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10072-020-04713-x","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T20:17:41Z","timestamp":1599769061000},"page":"1165-1167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Optic neuritis associated with sunitinib"],"prefix":"10.1007","volume":"42","author":[{"given":"Seunghee","family":"Na","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-1455","authenticated-orcid":false,"given":"Taewon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"issue":"5","key":"4713_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2174\/138920009788897975","volume":"10","author":"JT Hartmann","year":"2009","unstructured":"Hartmann JT, Haap M, Kopp HG, Lipp HP (2009) Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects. Curr Drug Metab 10(5):470\u2013481. https:\/\/doi.org\/10.2174\/138920009788897975","journal-title":"Curr Drug Metab"},{"issue":"7","key":"4713_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.1979.03300070019017","volume":"242","author":"MS Kramer","year":"1979","unstructured":"Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use. Jama 242(7):623\u2013632","journal-title":"Jama"},{"issue":"2","key":"4713_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1084\/jem.20072041","volume":"205","author":"AS Maharaj","year":"2008","unstructured":"Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, D'Amore PA (2008) VEGF and TGF-\u03b2 are required for the maintenance of the choroid plexus and ependyma. J Exp Med 205(2):491\u2013501","journal-title":"J Exp Med"},{"issue":"12","key":"4713_CR4","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1158\/1535-7163.MCT-10-1124","volume":"10","author":"G Aparicio-Gallego","year":"2011","unstructured":"Aparicio-Gallego G, Blanco M, Figueroa A, Garc\u00eda-Campelo R, Valladares-Ayerbes M, Grande-Pulido E, Ant\u00f3n-Aparicio L (2011) New insights into molecular mechanisms of sunitinib-associated side effects. Mol Cancer Ther 10(12):2215\u20132223","journal-title":"Mol Cancer Ther"},{"key":"4713_CR5","first-page":"1","volume":"2014","author":"Z Kanaan","year":"2014","unstructured":"Kanaan Z, Kulairi Z, Titianu M, Saha S, Kumar S (2014) Guillain-Barr\u00e9 syndrome following treatment with sunitinib malate. Case Rep Oncol Med 2014:1\u20132","journal-title":"Case Rep Oncol Med"},{"issue":"11","key":"4713_CR6","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4","volume":"21","author":"O Watanabe","year":"1998","unstructured":"Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, Matsuo K, Arisato T, Osame M (1998) Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow\u2013Fukase (POEMS) syndrome. Muscle Nerve 21(11):1390\u20131397","journal-title":"Muscle Nerve"},{"issue":"1","key":"4713_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10792-007-9038-9","volume":"27","author":"KG Babu","year":"2007","unstructured":"Babu KG, Attili VSS, Bapsy P, Anupama G (2007) Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia. Int Ophthalmol 27(1):43\u201344","journal-title":"Int Ophthalmol"},{"issue":"12","key":"4713_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10269-012-2148-7","volume":"14","author":"ME Deschamps","year":"2012","unstructured":"Deschamps ME, Provencal J (2012) Une n\u00e9vrite optique toxique induite par le sunitinib. Oncologie 14(12):679\u2013681. https:\/\/doi.org\/10.1007\/s10269-012-2148-7","journal-title":"Oncologie"},{"issue":"3","key":"4713_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.sjopt.2014.12.004","volume":"29","author":"KS Monge","year":"2015","unstructured":"Monge KS, G\u00e1lvez-Ruiz A, Alv\u00e1rez-Carr\u00f3n A, Quijada C, Matheu A (2015) Optic neuropathy secondary to dasatinib in the treatment of a chronic myeloid leukemia case. Saudi J Ophthalmol 29(3):227\u2013231","journal-title":"Saudi J Ophthalmol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04713-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04713-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04713-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:50:28Z","timestamp":1631235028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04713-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4713"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04713-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"assertion":[{"value":"14 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}